Danijela Tatovic (D Tatovic)

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Danijela Tatovic, Ashish Marwaha, Peter Taylor, Stephanie J Hanna, Kym Carter, Wai Yee Cheung, Steve Luzio, Gareth Dunseath, Hayley Anne Hutchings, Gail Holland, Steve Hiles, Gregory W Fegan, Evangelia Williams, Jennie Hsiu Mien Yang, Clara Domingo-Vila, Emily Pollock, Muntaha Wadud, Kirsten Ward-Hartstonge, Susie Marques-Jones, Jane Bowen-Morris, Rachel Stenson, Megan K Levings, John W Gregory, Timothy I M Tree, Colin Dayan, null null
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Nature medicine (2024)
Danijela Tatovic, M A McAteer, J Barry, A Barrientos, K Rodríguez Terradillos, I Perera, E Kochba, Y Levin, M Dul, S A Coulman, J C Birchall, C von Ruhland, A Howell, R Stenson, M Alhadj Ali, S D Luzio, G Dunseath, W Y Cheung, G Holland, K May, J R Ingram, M M U Chowdhury, F S Wong, R Casas, C Dayan, J Ludvigsson
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes. Immunotherapy advances 2 (1) (2022)
Danijela Tatovic, Angus G Jones, Carol Evans, Anna E Long, Kathleen M Gillespie, Rachel Elizabeth Jane Besser, Richard David Leslie, Colin M Dayan, null null
Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium. Diabetic medicine : a journal of the British Diabetic Association 39 (7) (2022)

Danijela Tatovic.css-eqlu8i{font-size:small;padding-left:4px;} (D Tatovic)